Summary
Osteoarthritis, a whole-joint degenerative disorder, is a major public health burden that affects nearly 600 million individuals worldwide. Molecular profiling of relevant tissues is crucial for understanding the biological mechanisms underlying disease development. We present the first comprehensive map of transcriptional regulation of disease-relevant primary tissues from knee osteoarthritis patients: macroscopically intact (low-grade, N=263) and degenerated (high-grade, N=216) cartilage, synovium (N=278), and fat pad (N=94). Of 9,738 unique expression quantitative trait loci (eQTL)-associated genes, 60.6% have not been reported previously. We identify 51 genes with directional evidence of tissue-specific colocalization and causal association with knee osteoarthritis, 25 of which are new high-confidence effector genes for osteoarthritis (including MUSTN1, which is implicated in cartilage integrity). Our study provides valuable insights into the tissue-specific and shared molecular mechanisms underlying osteoarthritis and offers drug repurposing opportunities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work on osteoarthritis cartilage samples was funded by Wellcome Trust (206194).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All study participants provided informed consent and samples were collected under Human Tissue Authority license 12182 and National Research Ethics Service approval 15/SC/0132 and 20/SC/0144, South Yorkshire and North Derbyshire Musculoskeletal Biobank, University of Sheffield, UK.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Summary statistics of all analyses will be shared through the Musculoskeletal Knowledge Portal (mskkp.org). All software used in this study is available from free repositories or manufacturers as referenced throughout the methods section.
